Evogene Ltd.
EVGN· Nasdaq
- Last sale
- Oct 1, 2026 · +10.07%
- Market cap
- $3.79M
- 8.72M shares
- Filings
- 458
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $3,853,000 | reported | |
| FY 2024 | 2024-12-31 | $5,577,000 revised | reported | |
| FY 2023 | 2023-12-31 | $2,982,000 revised | reported | |
| FY 2022 | 2022-12-31 | $1,675,000 | reported | |
| FY 2021 | 2021-12-31 | $930,000 | reported | |
| FY 2020 | 2020-12-31 | $1,040,000 | reported | |
| FY 2019 | 2019-12-31 | $753,000 | reported | |
| FY 2018 | 2018-12-31 | $1,747,000 | reported | |
| FY 2017 | 2017-12-31 | $3,381,000 | reported | |
| FY 2016 | 2016-12-31 | $6,540,000 | reported | |
| FY 2015 | 2015-12-31 | $11,129,000 | reported |
Evogene Ltd. · CIK 1574565 · Engraved from SEC EDGAR
